The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis

Drug and Alcohol Review

Volumn 28, Issue 3, 2009, Pages 250-256

  Hides, Leanne ^a,b   Kavanagh, David J ^c,d   Dawe, Sharon ^a   Young, Ross Mc D ^d  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Cannabis; Comorbidity; Expectancies; Motives; Psychosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTITUDE; CANNABIS ADDICTION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOSIS;

ADOLESCENT; ADULT; ATTITUDE; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 77049093041     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230802130158     Document Type: Article

References (43)

1. Degenhardt, L, Hall, W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med 2001;31:659-68.
2. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA 1990;264:2511-18.
3. Hides L, Dawe S, Kavanagh DJ, Young RM. Psychotic symptom and cannabis relapse in recent onset psychosis: prospective study. Br J Psychiatry 2006;189:137-43.
4. Jablensky A, Sartorius N, Ernberg F, et al. Schizophrenia: manifestations, incidence and course in different cultures. Psychol Med 1991;Suppl. 20:1-97.
5. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994;51:273-9.
6. van Os J, Bak M, Hanssen M, Bijl R, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population based study. Am J Epidemiol 2002;156:319-27.
7. Baker A, Bucci S, Lewin TJ, Kay-Lambkin F, Constable PM, Vaughan JC. Randomised controlled trial of cognitive behaviour therapy for substance use disorders among people with a psychotic disorder. Br J Psychiatry 2006;188:439-48.
8. Barrowclough C, Haddock G, Tarrier N, et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry 2001;158:1706-13.
9. Haddock GB, Barrowclough C, Tarrier N, et al. Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial. Br J Psychiatry 2003;183:418-26.
10. Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997;96:329-33.
11. Baigent M, Holme G, Hafner RJ. Self reports of the interaction between substance abuse and schizophrenia. Aust NZ J Psychiatry 1995;29:69-74.
12. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 1991;148:224-30.
13. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998;24:443-55.
14. Schofield D, Tennant CC, Nash L, et al. Reasons for cannabis use in psychosis. Aust NZ J Psychiatry 2006; 40:570-4.
15. Test MA, Wallisch LS, Allness DJ, Ripp K. Substance use in young adults with schizophrenic disorders. Schizophr Bull 1989;15:465-76.
16. Warner R, Taylor D, Wright J, et al. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. Am J Orthopsychiatry 1994;64:30-9.
17. Green B, Kavanagh D, Young R. Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 2003; 22:453-60.
18. Mueser KT, Pallavi N, Tracy JI, DeGirolamo J, Molinaro M. Expectations and motives for substance use in schizophrenia. Schizophr Bull 1995;21:367-78.
19. Spencer C, Castle D, Michie PT. Motivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull 2002;28:233-47.
20. McGuffin P, Farmer AE, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991;48:764-70.
21. Young RM, Kavanagh DJ. The Cannabis Expectancy Profile (CEP). Brisbane: University of Queensland, 1997.
22. Lyons M. The Cannabis Expectancy Profile: a psychometric analysis [unpublished Masters of Clinical Psychology thesis]. Brisbane: University of Queensland, 2002.
23. Young RM, Knight RG. The Drinking Expectancy Questionnaire: a revised measure of alcohol related beliefs. J Psychopathol Behav Assess 1989;11:99-112.
24. World Health Organisation. Composite International Diagnostic Interview: version 2.1. Geneva: World Health Organisation, 1997.
25. Fals Stewart W, O'Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The Timeline Followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 2000; 68:134-44.
26. Sobell LC, Sobell MB. Timeline Followback: a technique for assessing self-reported alcohol consumption. In: Litten R, Allen J, eds. Measuring alcohol consumption: psychosocial and biological methods. Totowa, NJ: Humana Press, 1992:41-72.
27. Gossop M, Darke S, Griffiths P, Hando J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:607-14.
28. Hides L, Dawe S, Young RM, Kavanagh DJ. The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis. Addiction 2007;102:35-40.
29. Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction 1993;88:791-804.
30. Dawe S, Seinen A, Kavanagh D. An examination of the utility of the AUDIT in people with schizophrenia. J Stud Alcohol 2000;61:744-50.
31. Maisto SA, Conigliaro J, McNeil M, Kraemer K, Kelley ME. An empirical investigation of the factor structure of the AUDIT Psychological Assessment. Psychol Assess 2000; 12:346-53.
32. Kay SR, Opler LA, Lindemeyer JP. The positive and negative syndrome scale (PANSS): rationale and standardisation. Br J Psychiatry 1989;155(Suppl. 7):53-65.
33. Tabachnick BG, Fidell LS. Using multivariate statistics, 4th edn. NewYork: HarperCollins, 2001.
34. Mueser KT, Yarnold PR, Rosenberg SD, Swett C, Miles KM, Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr Bull 2000;26:179-92.
35. Green B, Kavanagh DJ, Young RM. Predictors of cannabis use in men with and without psychosis. Addict Behav 2007;32:2879-87.
36. Addington J, Addington D. Effect of substance misuse in early psychosis. Br J Psychiatry 1998;172(Suppl. 33):134-6.
37. Gut-Fayand A, Dervaux A, Olie J-P, Loo H, Poirier M-F, Krebs M-O. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatr Res 2001;102:65-72.
38. Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand 1992;85:127-30.
39. Sevy S, Robinson DG, Holloway S, et al. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 2001;104:367-74.
40. Green B, Kavanagh D, Young RM. Reasons for cannabis use in men with and without psychosis. Drug Alcohol Rev 2004;23:445-53.
41. Pencer A, Addington D. Reasons for using substances in adolescents with and without psychosis. Early Interven Psychiatry 2008;2:42-4.
42. Brown SA. Drug effect expectancies and addictive behaviour change. Exp Clin Psychopharmacol 1993;1:55-67.
43. McPhillips MA, Kelly FJ, Barnes TRE, Duke PJ, Gene-Cos N, Clark K. Detecting comorbid substance misuse among people with schizophrenia in the community: a study comparing the results of questionnaires with analysis of hair and urine. Schizophr Res 1997;25:141-8.